Yi Liu

机构：North University of China, King's College London, Second Affiliated Hospital of Dalian Medical University · ORCID：0000-0002-2943-2144

发表论文 82 篇 · 总被引 1093 次 · h-index 19

代表论文

• Folate receptor alpha for cancer therapy: an antibody and antibody-drug conjugate target coming of age (2025 · mAbs · 被引 17)
• Identification of gastric cancer stem cells with CD44 and Lgr5 double labelling and their initial roles on gastric cancer malignancy and chemotherapy resistance (2024 · Cell Biology and Toxicology · 被引 7)
• BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression (2024 · Frontiers in Endocrinology · 被引 4)
• Tuning antibody stability and function by rational designs of framework mutations (2025 · mAbs · 被引 3)
• Pan-cancer analysis shows that TRIP13 as a potential prognostic and immunotherapeutic biomarker for multiple cancer types including LIHC and LUAD (2025 · Medicine · 被引 3)
• Identification and Validation of Four Serum Biomarkers With Optimal Diagnostic and Prognostic Potential for Gastric Cancer Based on Machine Learning Algorithms (2025 · Cancer Medicine · 被引 3)